drugset / Trial / NCT02827942
Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients infected with H. pylori were randomly assigned to the dual therapy with vonoprazan 20 mg bid and amoxicillin 500 mg tid for 1 week or the triple therapy with vonoprazan 20 mg bid, amoxicillin 750 mg bid and clarithromycin 200 mg or metronidazole 250 mg bid bid for 1 week. Success or failure of eradication was determined by the 13C-urea breath test performed at 1 month after the therapy.
Timeline
- Start
- 2016-07-01
- Primary completion
- 2018-12-31
- Completion
- 2019-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 500 mg | — |
| Subject | Amoxicillin | Other / unclassified | 750 mg | — |
| Comparator | Clarithromycin | Small molecule | 200 mg | — |
| Comparator | Metronidazole | Small molecule | 250 mg | — |
| Subject | Vonoprazan | Other / unclassified | 20 mg | — |